88 related articles for article (PubMed ID: 2723030)
1. Reciprocal changes in parathyroid hormone and thyroid function after radioiodine treatment of hyperthyroidism.
Ross DS; Nussbaum SR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1216-9. PubMed ID: 2723030
[TBL] [Abstract][Full Text] [Related]
2. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine.
Davies PH; Franklyn JA; Daykin J; Sheppard MC
J Clin Endocrinol Metab; 1992 May; 74(5):1189-94. PubMed ID: 1569166
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function surveillance in CAPD patients.
Dumler F; Bello MJ; Cruz C; Gotaas KA; Macks H
Adv Perit Dial; 1995; 11():225-8. PubMed ID: 8534710
[TBL] [Abstract][Full Text] [Related]
4. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
6. Delayed recovery of thyrotropin responsiveness after radioactive iodine therapy for hyperthyroidism.
Albert SG; Goodgold HM; Chehade J; Kim J
Am J Med Sci; 2000 Jun; 319(6):376-9. PubMed ID: 10875293
[TBL] [Abstract][Full Text] [Related]
7. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
8. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
9. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.
Boucher A; D'Amour P; Hamel L; Fugère P; Gascon-Barré M; Lepage R; Ste-Marie LG
J Clin Endocrinol Metab; 1989 Apr; 68(4):831-6. PubMed ID: 2921312
[TBL] [Abstract][Full Text] [Related]
10. Hypoparathyroidism after I-131 therapy with subsequent return of parathyroid function.
Burch WM; Posillico JT
J Clin Endocrinol Metab; 1983 Aug; 57(2):398-401. PubMed ID: 6863481
[TBL] [Abstract][Full Text] [Related]
11. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
Ross DS; Ardisson LJ; Nussbaum SR; Meskell MJ
J Clin Endocrinol Metab; 1991 Feb; 72(2):507-9. PubMed ID: 1991818
[TBL] [Abstract][Full Text] [Related]
13. [Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment].
Furlanetto RP; Castro ML; de Mesquita CH; Kasamatsu TS; Vieira JG
Rev Paul Med; 1991; 109(2):55-60. PubMed ID: 1909454
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid Changes After RAI in Patients With Differentiated Thyroid Carcinoma.
Xiao L; Zhang W; Zhu H; Wang Y; Liu B; Huang R; Li L
Front Endocrinol (Lausanne); 2021; 12():671787. PubMed ID: 34122347
[TBL] [Abstract][Full Text] [Related]
16. Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease.
Fraser WD; Logue FC; MacRitchie K; Wilson RM; Gray HW; Beastall GH; O'Reilly DS
Acta Endocrinol (Copenh); 1991 Jun; 124(6):652-7. PubMed ID: 1648852
[TBL] [Abstract][Full Text] [Related]
17. Serum T3 level in the patients with hyperthyroidism after therapy.
Hachiya T; Ochi Y; Yoshimura M; Miyazaki T
Endocrinol Jpn; 1975 Jun; 22(3):255-60. PubMed ID: 1175526
[TBL] [Abstract][Full Text] [Related]
18. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
Sawin CT; Geller A; Kaplan MM; Bacharach P; Wilson PW; Hershman JM
Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
20. Effect of iodine upon the TRH induced release of TSH in euthyroid, hypothyroid and hyperthyroid individuals.
Waldhäusl W; Haydl H
Horm Metab Res; 1976 Jul; 8(4):286-91. PubMed ID: 821840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
